<bill session="116" type="h" number="5281" updated="2022-10-28T01:46:07Z">
  <state datetime="2019-12-03">REFERRED</state>
  <status>
    <introduced datetime="2019-12-03"/>
  </status>
  <introduced datetime="2019-12-03"/>
  <titles>
    <title type="display">Drug Price Transparency in Medicaid Act of 2019</title>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.</title>
    <title type="short" as="introduced">Drug Price Transparency in Medicaid Act of 2019</title>
  </titles>
  <sponsor bioguide_id="C001103"/>
  <cosponsors>
    <cosponsor bioguide_id="C001097" joined="2019-12-03"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-03">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-12-03" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-12-04">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="3" relation="unknown"/>
    <bill session="116" type="h" number="19" relation="unknown"/>
    <bill session="116" type="s" number="2543" relation="unknown"/>
    <bill session="116" type="s" number="4199" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Congressional oversight"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Home and outpatient care"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Retail and wholesale trades"/>
    <term name="State and local government operations"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-11T19:55:55Z" status="Introduced in House">Drug Price Transparency in Medicaid Act of 2019

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.</summary>
</bill>
